XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2023
Jul. 23, 2021
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2022
Stock-Based Compensation (Details) [Line Items]                    
Performance stock and performance stock units     0   354,646   133,922 427,041    
Shares issued, shares     0   354,646   133,922 427,041    
Weighted average grant-date fair value of options granted (in Dollars per share)       $ 1.17   $ 1.77        
Number of Shares, Granted       204,254            
Unrecognized compensation cost related to nonvested stock options grant (in Dollars)     $ 32,800       $ 32,800      
Weighted-average over period             1 year 7 months 6 days      
Selling, general and administrative     $ 16,844   $ 20,975   $ 35,543 $ 43,211    
Stock-based compensation expense             27,974 27,983    
Third anniversary [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share prices of our common stock                   $ 24.20
Common stock equals or exceeds (in Dollars per share)                   $ 24.20
Neat PHA Production Capacity Metric [Member] | Maximum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value   $ 90,000                
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars)   90,000                
Neat PHA Production Capacity Metric [Member] | Minimum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value   75,000                
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars)   $ 75,000                
Restricted Stock [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Weighted average grant-date fair value of options granted (in Dollars per share)       $ 2.62            
Number of Shares, Granted     152,822 6,250            
Stock-based compensation expense     $ 4,700   4,800   $ 9,200 9,500    
Performance Shares [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Performance stock and performance stock units             1,048,411      
Shares issued, shares             1,048,411      
Restricted stock shares 462,519 95,943       489,949        
Long term liability     500       $ 500      
Performance Shares [Member] | Selling, general and administrative [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Stock-based compensation expense     100       300      
Performance Shares [Member] | ROE [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Vesting description   30% of the shares are subject to a return on equity "ROE" metric based on 2023 financial results. 50% of these shares vest if ROE is 5%, 100% vest if ROE is 9% or higher, with prorated vesting between 5% and 9%.                
Performance Shares [Member] | ROE [Member] | Maximum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Vesting percentage   9.00%                
Performance Shares [Member] | ROE [Member] | Minimum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Vesting percentage   5.00%                
Performance Shares [Member] | EBITDA Metric [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Vesting description 50% of the shares are subject to an Adjusted EBITDA Metric based on 2025 financial results. 50% of these shares vest if Adjusted EBITDA is $36 million, 100% vest if Adjusted EBITDA is $44 million or higher, with prorated vesting between $36 million and $44 million. 0% of the shares are subject to an EBITDA Metric based on 2023 financial results. 50% of these shares vest if EBITDA is $45 million, 100% vest if EBITDA is $65 million or higher, with prorated vesting between $45 million and $65 million.       30% of the shares are subject to an Adjusted EBITDA Metric based on 2024 financial results. 50% of these shares vest if Adjusted EBITDA is $9.2 million, 100% vest if Adjusted EBITDA is $13.8 million or higher, with prorated vesting between $9.2 million and $13.8 million.        
Performance Shares [Member] | EBITDA Metric [Member] | Maximum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value $ 44,000 $ 65,000       $ 13,800        
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars) 44,000 65,000       13,800        
Performance Shares [Member] | EBITDA Metric [Member] | Minimum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value 36,000 45,000       9,200        
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars) $ 36,000 $ 45,000       $ 9,200        
Performance Shares [Member] | Neat PHA Production Capacity Metric [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Vesting description 50% of the shares are subject to a total PHA revenue metric based on 2025 financial results. 50% of these shares vest if total PHA revenue is $177 million, 100% vest if total PHA revenue is $202 million or higher, with prorated vesting between $177 million and $202 million 40% of the shares are subject to a Neat PHA production capacity metric based on a third party assessment at December 31, 2023, 50% of the shares vest if capacity is 75 million pounds, 100% vest if capacity is 90 million pounds or higher, with prorated vesting between 75 million pounds and 90 million pounds.       40% of the shares are subject to a Neat PHA production capacity metric based on a third party assessment at December 31, 2024, 50% of the shares vest if capacity is 68 million pounds, 100% vest if capacity is 81 million pounds or higher, with prorated vesting between 68 million pounds and 81 million pounds.        
Performance Shares [Member] | Neat PHA Production Capacity Metric [Member] | Maximum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value $ 202,000         $ 81,000        
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars) 202,000         81,000        
Performance Shares [Member] | Neat PHA Production Capacity Metric [Member] | Minimum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value 177,000         68,000        
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars) $ 177,000         $ 68,000        
Performance Shares [Member] | Neat PHA Revenue Metric [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Vesting description           30% of the shares are subject to a total PHA revenue metric based on 2024 financial results. 50% of these shares vest if total PHA revenue is $151 million, 100% vest if total PHA revenue is $189 million or higher, with prorated vesting between $151 million and $189 million.        
Performance Shares [Member] | Neat PHA Revenue Metric [Member] | Maximum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value           $ 189,000        
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars)           189,000        
Performance Shares [Member] | Neat PHA Revenue Metric [Member] | Minimum [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value           151,000        
Share-based Compensation Arrangement fair value of shares vested amount (in Dollars)           $ 151,000        
Stock Option                    
Stock-Based Compensation (Details) [Line Items]                    
Long term liability     500       500      
Stock Option | Selling, general and administrative [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Stock-based compensation expense     200       400      
Market Based Restricted Shares [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Number of Shares, Granted                 1,517,840  
Stock-based compensation expense     $ 4,600   $ 4,600   $ 9,300 $ 9,200    
Cash Settled Options [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Performance stock and performance stock units             920,641      
Shares issued, shares             920,641      
Number of Shares, Granted       1,050,000   972,222        
2020 ESPP [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Performance stock and performance stock units             85,146      
ESPP plan, percentage of stock discount             15.00%      
Share-based compensation, authorized shares     2,571,737       2,571,737      
Share-based compensation, issued shares             163,314      
Shares issued, shares             85,146      
2020 Incentive Plan [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Share-based compensation, remained authorized for Issuance     1,339,279       1,339,279     1,657,244